News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CardioMEMS Presented the Phoenix 2011 Most Promising New Product Award


10/27/2011 2:15:11 PM

ATLANTA, Oct. 27, 2011 /PRNewswire/ -- CardioMEMS, Inc., an Atlanta-based medical technology company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, today announced that it has been honored with the prestigious Phoenix 2011 Most Promising New Product Award for the CardioMEMS Champion® Heart Failure Monitoring System. Founder and CEO Jay Yadav, M.D., was presented with the award on October 14 during the Hall of Fame Awards Ceremony held in conjunction with the Phoenix: Medical Device and Diagnostic Conference for Chief Executive Officers, in Scottsdale, Arizona.

The Phoenix Awards are presented yearly for outstanding achievement in the medical device and diagnostic industry to individuals and companies selected by industry executives and CEOs. Past recipients of the Most Promising New Product Award include Balloon Sinuplasty Technology (Acclarent), Merci Retrieval System® (Concentric Medical), CyberKnife® (Accuray), Essure® (Conceptus), Drug Eluting Stent (Cordis), Electrostimulation Devices for Epilepsy (Cyberonics), Spinal Cages (Sulzer Spine-Tech), Percutaneous Vascular Surgery Products (Perclose), Implantable Defibrillator (Intec, Guidant Corp.), and Coronary Stents (Johnson & Johnson).

"We believe the CardioMEMS Heart Failure Monitoring System will prove be to a significant step forward in the management of heart failure patients," said Dr. Yadav. "I am honored to accept this award on behalf of the CardioMEMS team that has worked tirelessly to develop our unique technology."

About Phoenix: The Medical Device and Diagnostic Conference for Chief Executive Officers

Phoenix: The Medical Device and Diagnostic Conference for Chief Executive Officers began in 1994. The conference was developed to provide CEOs in the Medical Device and Diagnostic Industries with an opportunity to meet with peers and explore issues critical to the success of their companies and industries. During the conference, inductees include the Most Promising New Product Award, the Emerging Growth Company Award, the Lifetime Achievement Award, and the Innovator Award.

About CardioMEMS, Inc.

CardioMEMS is a medical device company that has developed and is commercializing proprietary wireless sensing and communication technology for the human body. The Company's technology platform is designed to improve the management of severe chronic cardiovascular diseases such as aneurysms, heart failure and hypertension. CardioMEMs miniature wireless sensors can be implanted using minimally-invasive techniques and transmit cardiac output, blood pressure and heart rate data which are critical to the management of patients. The sensors are designed to be permanently implanted into the heart and blood vessels due to their small size, durability and lack of wires and batteries. Using radiofrequency energy, the sensors transmit real-time data to external electronic readers, which then communicate this information to the patient's physician. The Company developed this technology based on the belief that frequent, on-demand, real-time monitoring of vital information enables proactive patient management, which holds the promise of reducing hospitalizations, improving a patient's quality of life and delivering more efficient and cost effective health care. More information about the CardioMEMs is located at www.cardiomems.com.

Statements made in this press release that look forward in time or that express beliefs, expectations or hopes regarding future occurrences or anticipated outcomes are forward-looking statements. A number of risks and uncertainties such as risks associated with product development and commercialization efforts, expected timing or results of any clinical trials, ultimate clinical outcome and perceived or actual advantages of the Company's products, market and physician acceptance of the products, intellectual property protection, and competitive offerings could cause actual events to adversely differ from the expectations indicated in these forward looking statements.

CardioMEMS, Champion and the CardioMEMS logo are registered trademarks of CardioMEMS, Inc.

Merci Retrieval System® is a registered trademark Concentric Medical.

CyberKnife® is a registered trademark of Accuray, Inc.

Essure® is a registered trademark of Conceptus, Inc.

Caution: The Champion Heart Failure Monitoring System is an investigational device limited by federal law to investigational use.

SOURCE CardioMEMS, Inc.


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES